Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 292

1.

Downregulation of microRNA-124 is an independent prognostic factor in patients with colorectal cancer.

Wang MJ, Li Y, Wang R, Wang C, Yu YY, Yang L, Zhang Y, Zhou B, Zhou ZG, Sun XF.

Int J Colorectal Dis. 2013 Feb;28(2):183-9. doi: 10.1007/s00384-012-1550-3. Epub 2012 Aug 11.

PMID:
22885837
2.

Up-regulation of miR-182 expression in colorectal cancer tissues and its prognostic value.

Liu H, Du L, Wen Z, Yang Y, Li J, Wang L, Zhang X, Liu Y, Dong Z, Li W, Zheng G, Wang C.

Int J Colorectal Dis. 2013 May;28(5):697-703. doi: 10.1007/s00384-013-1674-0. Epub 2013 Mar 10.

PMID:
23474644
3.

Clinical significance of microRNA-93 downregulation in human colon cancer.

Xiao ZG, Deng ZS, Zhang YD, Zhang Y, Huang ZC.

Eur J Gastroenterol Hepatol. 2013 Mar;25(3):296-301. doi: 10.1097/MEG.0b013e32835c077a.

PMID:
23354160
4.

Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer.

Wang X, Wang J, Ma H, Zhang J, Zhou X.

Med Oncol. 2012 Jun;29(2):919-27. doi: 10.1007/s12032-011-9880-5. Epub 2011 Mar 10.

PMID:
21390519
5.

Overexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancer.

Zhou T, Zhang G, Liu Z, Xia S, Tian H.

Int J Colorectal Dis. 2013 Jan;28(1):19-24. doi: 10.1007/s00384-012-1528-1. Epub 2012 Jul 7.

PMID:
22772712
6.

Prognostic significance of microRNA-16 expression in human colorectal cancer.

Qian J, Jiang B, Li M, Chen J, Fang M.

World J Surg. 2013 Dec;37(12):2944-9. doi: 10.1007/s00268-013-2205-4.

PMID:
24045965
7.

Decreased expression of miR-133a correlates with poor prognosis in colorectal cancer patients.

Wang LL, Du LT, Li J, Liu YM, Qu AL, Yang YM, Zhang X, Zheng GX, Wang CX.

World J Gastroenterol. 2014 Aug 28;20(32):11340-6. doi: 10.3748/wjg.v20.i32.11340.

8.

Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer.

Yang Q, Zhang C, Huang B, Li H, Zhang R, Huang Y, Wang J.

Eur J Gastroenterol Hepatol. 2013 Aug;25(8):953-7. doi: 10.1097/MEG.0b013e32835ed691.

PMID:
23751352
9.

Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer.

Fukushima Y, Iinuma H, Tsukamoto M, Matsuda K, Hashiguchi Y.

Oncol Rep. 2015 Feb;33(2):573-82. doi: 10.3892/or.2014.3614. Epub 2014 Nov 21.

PMID:
25421755
10.

Clinical significance of miR-22 expression in patients with colorectal cancer.

Zhang G, Xia S, Tian H, Liu Z, Zhou T.

Med Oncol. 2012 Dec;29(5):3108-12. doi: 10.1007/s12032-012-0233-9. Epub 2012 Apr 11.

PMID:
22492279
11.

Invasion front-specific expression and prognostic significance of microRNA in colorectal liver metastases.

Kahlert C, Klupp F, Brand K, Lasitschka F, Diederichs S, Kirchberg J, Rahbari N, Dutta S, Bork U, Fritzmann J, Reissfelder C, Koch M, Weitz J.

Cancer Sci. 2011 Oct;102(10):1799-807. doi: 10.1111/j.1349-7006.2011.02023.x. Epub 2011 Aug 4.

12.

Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer.

Zhang P, Ji DB, Han HB, Shi YF, Du CZ, Gu J.

World J Gastroenterol. 2014 Sep 14;20(34):12241-8. doi: 10.3748/wjg.v20.i34.12241.

13.

Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer.

Inoue T, Iinuma H, Ogawa E, Inaba T, Fukushima R.

Oncol Rep. 2012 Jun;27(6):1759-64. doi: 10.3892/or.2012.1709. Epub 2012 Mar 7.

PMID:
22407237
14.

Prognostic significance of PDCD4 expression and association with microRNA-21 in each Dukes' stage of colorectal cancer patients.

Horiuchi A, Iinuma H, Akahane T, Shimada R, Watanabe T.

Oncol Rep. 2012 May;27(5):1384-92. doi: 10.3892/or.2012.1648. Epub 2012 Jan 19.

PMID:
22267128
15.

Down-regulation of miR-24-3p in colorectal cancer is associated with malignant behavior.

Gao Y, Liu Y, Du L, Li J, Qu A, Zhang X, Wang L, Wang C.

Med Oncol. 2015 Jan;32(1):362. doi: 10.1007/s12032-014-0362-4. Epub 2014 Dec 13.

PMID:
25502080
16.

SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer.

Wang F, Ma YL, Zhang P, Shen TY, Shi CZ, Yang YZ, Moyer MP, Zhang HZ, Chen HQ, Liang Y, Qin HL.

J Pathol. 2013 Jan;229(1):12-24. doi: 10.1002/path.4078.

PMID:
22821729
17.

Prognostic implications of serum microRNA-21 in colorectal cancer.

Menéndez P, Padilla D, Villarejo P, Palomino T, Nieto P, Menéndez JM, Rodríguez-Montes JA.

J Surg Oncol. 2013 Nov;108(6):369-73. doi: 10.1002/jso.23415. Epub 2013 Aug 23.

PMID:
23970420
18.

Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer.

Wang CJ, Zhou ZG, Wang L, Yang L, Zhou B, Gu J, Chen HY, Sun XF.

Dis Markers. 2009;26(1):27-34. doi: 10.3233/DMA-2009-0601.

19.

[Correlation of miR-195 with invasiveness and prognosis of breast cancer].

Song CG, Wu XY, Wang C, Fu FM, Shao ZM.

Zhonghua Wai Ke Za Zhi. 2012 Apr;50(4):353-6. Chinese.

PMID:
22800791
20.

Overexpression of microRNA-183 in human colorectal cancer and its clinical significance.

Zhou T, Zhang GJ, Zhou H, Xiao HX, Li Y.

Eur J Gastroenterol Hepatol. 2014 Feb;26(2):229-33. doi: 10.1097/MEG.0000000000000002.

PMID:
24150523

Supplemental Content

Support Center